Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
Karyopharm Therapeutics (KPTI) Ownership Overview
4.45% Insiders
20.90% Mutual Funds
31.29% Other Institutional Investors
4.09% ETFs
39.27% Public Companies and
Individual Investors
The ownership structure of Karyopharm Therapeutics (KPTI) stock is a mix of institutional, retail, and individual investors. Approximately 56.28% of the company’s stock is owned by Institutional Investors, 4.45% is owned by Insiders, and 39.27% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,125,000 | Institution | 6.13% | 9,450,000 | |
| 858,964 | Institution | 4.68% | 7,215,298 | |
| 702,950 | Institution | 3.83% | 5,904,780 | |
| 566,666 | Institution | 3.09% | 4,759,994 | |
| 439,550 | Institution | 2.40% | 3,692,220 | |
| 402,887 | Institution | 2.20% | 3,384,251 | |
| 279,391 | Insider | 1.52% | 2,346,884 | |
| 169,383 | Institution | 0.92% | 1,422,817 | |
| 134,112 | Institution | 0.79% | 848,929 | |
| 111,921 | Insider | 0.61% | 940,136 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,125,000 | Institution | 6.13% | 9,450,000 | |
| 858,964 | Institution | 4.68% | 7,215,298 | |
| 566,666 | Institution | 3.09% | 4,759,994 | |
| 439,550 | Institution | 2.40% | 3,692,220 | |
| 402,887 | Institution | 2.20% | 3,384,251 | |
| 169,383 | Institution | 0.92% | 1,422,817 | |
| 66,818 | Institution | 0.36% | 561,271 | |
| 65,873 | Institution | 0.36% | 553,333 | |
| 46,618 | Institution | 0.25% | 391,591 | |
| 43,876 | Institution | 0.24% | 368,558 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 509,129 | Institution | 2.78% | 4,790,904 | |
| 185,842 | Institution | 1.01% | 1,748,773 | |
| 42,012 | Institution | 0.23% | 44,533 | |
| 39,661 | Institution | 0.22% | 333,152 | |
| 7,870 | Institution | 0.04% | 67,289 |
FAQ
Who Owns Karyopharm Therapeutics (KPTI)?
According to the latest TipRanks data, approximately 31.29% of the company's stock is held by institutional investors, 4.45% is held by insiders, and 39.27% is held by retail investors.
What percentage of Karyopharm Therapeutics (KPTI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.29% of Karyopharm Therapeutics (KPTI) stock is held by institutional investors.
What percentage of Karyopharm Therapeutics (KPTI) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.27% of Karyopharm Therapeutics (KPTI) stock is held by retail investors.
Who owns the most shares of Karyopharm Therapeutics (KPTI)?
MUTUAL FUND SERIES TRUST owns the most shares of Karyopharm Therapeutics (KPTI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.